Publications by authors named "James A Kaye"

Claim this Profile
V
Validation of an ICD-10 case-finding algorithm for endometrial cancer in US insurance claims.
Djeneba Audrey Djibo, Andrea V Margulis, Cheryl N McMahill-Walraven, Catherine W Saltus, Patricia Shuminski, James A Kaye

Pharmacoepidemiol Drug Saf· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The application of lag times in cancer pharmacoepidemiology: a narrative review.
Blánaid Hicks, James A Kaye, Laurent Azoulay, Kasper Bruun Kristensen, Laurel A Habel

Ann Epidemiol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the USA.
Naleen Raj Bhandari, Lisa M Hess, Rohan C Parikh, Anthony N Sireci, Peter M Krein, James A Kaye

Per Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database.
Catherine B Johannes, Catherine W Saltus, James A Kaye, Brian Calingaert, Sigal Kaplan

Pharmacoepidemiol Drug Saf· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum lipid trajectories in the years before a lymphoma diagnosis.
Joan Fortuny, Estel Plana, James A Kaye

Leuk Lymphoma· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancer.
Rohan Parikh, Lisa M Hess, Elizabeth Esterberg, Naleen Raj Bhandari, James A Kaye

Thyroid Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: physician preferences trading off benefits, risks and time to infusion.
Marco Boeri, Anna G Purdum, Jessie Sutphin, Brett Hauber, James A Kaye

Future Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE).
Alejandro Arana, Anton Pottegård, Josephina G Kuiper, Helen Booth, Johan Reutfors, James A Kaye

Clin Epidemiol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2- metastatic breast cancer in the United States.
Ravi K Goyal, Gebra Cuyun Carter, Saurabh P Nagar, Emily Nash Smyth, Gregory L Price, James A Kaye

Expert Rev Pharmacoecon Outcomes Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphoma.
Ravi K Goyal, Preetesh Jain, Saurabh P Nagar, Hannah Le, Shaum M Kabadi, James A Kaye

Leuk Lymphoma· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application.
David Richardson, Lin Zhan, Reshma Mahtani, Lynn McRoy, Debanjali Mitra, James A Kaye

Breast Cancer Res Treat· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA testing and outcomes in women with breast cancer.
David D Stenehjem, Claire Telford, Sudhir K Unni, Hillevi Bauer, Amy Sainski, James A Kaye

Breast Cancer Res Treat· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real-world evidence from the medicare population.
Ravi K Goyal, Saurabh P Nagar, Shaum M Kabadi, Hannah Le, Keith L Davis, James A Kaye

Cancer Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of second primary malignancies in metastatic castration-resistant prostate cancer: results from observational studies in three countries.
Zdravko P Vassilev, Montse Soriano Gabarró, James A Kaye, Catherine W Saltus, Oliver Riedel

Future Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma.
Jan Bassali, Ian Gopal Gould, James A Kaye, Deirdre Mladsi, Jyotsna Mehta

Clinicoecon Outcomes Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical management patterns of advanced and metastatic gastro-oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom.
Jacqueline Brown, Astra M Liepa, Bela Bapat, Shweta Madhwani, Sylvie Lorenzen, James A Kaye

Eur J Cancer Care (Engl)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2- metastatic breast cancer.
Ravi K Goyal, Gebra Cuyun Carter, Saurabh P Nagar, Emily N Smyth, Gregory L Price, James A Kaye

Curr Med Res Opin· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors.
Muhammad Wasif Saif, Rohan Parikh, David Ray, James A Kaye, Samantha K Kurosky

J Gastrointest Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States.
Shaum M Kabadi, Ravi K Goyal, Saurabh P Nagar, James A Kaye, Keith L Davis

Cancer Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States".
Catherine W Saltus, Zdravko P Vassilev, Jihong Zong, Brian Calingaert, Elizabeth B Andrews, James A Kaye

Prostate Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Skeletal-Related Events in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US.
Alison Tse Kawai, David Martinez, Catherine W Saltus, Zdravko P Vassilev, Montse Soriano-Gabarró, James A Kaye

Prostate Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis.
Adrian D Vickers, Katherine B Winfree, Gebra Cuyun Carter, Urpo Kiiskinen, Min-Hua Jen, James A Kaye

BMC Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of sequencing of ALK inhibitors in -positive non-small-cell lung cancer.
Stephanie M Barrows, Kelly Wright, Catherine Copley-Merriman, James A Kaye, Marc Chioda

Lung Cancer (Auckl)· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States.
Catherine W Saltus, Zdravko P Vassilev, Jihong Zong, Brian Calingaert, Elizabeth B Andrews, James A Kaye

Prostate Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France.
Huamao Mark Lin, Keith L Davis, James A Kaye, Katarina Luptakova, Saurabh P Nagar

Adv Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis